Loading…
Loading…
research
Coave Therapeutics is a clinical-stage biotechnology company based in Paris, France. The company specializes in targeted gene therapies using its proprietary ALIGATER™ platform, which enhances the precision and safety of treatments for rare ocular, central nervous system, neuromuscular, and neurodegenerative diseases. Coave develops first-in-class ligand-conjugated AAV vectors that are designed for highly specific tissue delivery, including innovative approaches for retinal vascular diseases. The company's lead program, CoTx-101, is advancing toward clinical development as a durable treatment for retinal diseases, aiming to reduce the need for frequent injections while providing sustained vision improvements. Coave has a broader pipeline of preclinical assets targeting various conditions and plans to advance two candidates to clinical studies in 2026. With significant funding from notable investors, Coave Therapeutics is focused on translating innovative science into effective therapies through its expertise in AAV vector engineering and therapeutic development.
Coave Therapeutics is a clinical-stage biotechnology company based in Paris, France. The company specializes in targeted gene therapies using its proprietary ALIGATER™ platform, which enhances the precision and safety of treatments for rare ocular, central nervous system, neuromuscular, and neurodegenerative diseases. Coave develops first-in-class ligand-conjugated AAV vectors that are designed for highly specific tissue delivery, including innovative approaches for retinal vascular diseases. The company's lead program, CoTx-101, is advancing toward clinical development as a durable treatment for retinal diseases, aiming to reduce the need for frequent injections while providing sustained vision improvements. Coave has a broader pipeline of preclinical assets targeting various conditions and plans to advance two candidates to clinical studies in 2026. With significant funding from notable investors, Coave Therapeutics is focused on translating innovative science into effective therapies through its expertise in AAV vector engineering and therapeutic development.
Coave Therapeutics has been mentioned across 1 podcast.
Represent this company? Request removal or email privacy@pitchcentric.com.
FAQs
If you have a concern about deliverability, AI quality, data privacy, or whether this will actually work for your specific situation, it's probably answered below.
Founder Solo gives you 50 AI pitches per month using the credit model (Standard pitches cost 1 credit, Enriched pitches cost 2). Founder Pro raises that to 200 credits per month and adds full Booking Probability access, unlimited Magic Match, Apollo enrichment credits, and data export capabilities. Both plans use the same credit system, so you can stretch your monthly budget further by using Standard-mode drafting.
Agency tiers have no base fee. You pay per managed client and per talent profile. Agency Standard is $199 per client per month; Agency Pro is $399 per client per month. Both add $39 per talent profile per month. Your own team's user seats are always free.
A talent profile represents one person (founder, executive, or spokesperson) you are booking onto podcasts. It includes their bio, topics, headshots, and outreach history. Team plans include 5 profiles; agency plans are pay-as-you-go.
Yes, at any time. Upgrades take effect immediately; downgrades apply at the end of the current billing period. Contact support if you need help migrating between plan families.
Every paid plan includes a 15-day free trial. Your card is saved at signup but you will not be charged until day 16. Cancel any time from your dashboard.
You keep access until the end of your current billing period. No charges after that. Your data is retained for 30 days in case you reactivate.
Yes. Select Annual on the pricing toggle and the discounted price is applied automatically at checkout. The annual price shown is the full year cost.
That is our Enterprise tier. Contact our sales team and we will build a custom plan with volume pricing, a dedicated account manager, and SLA guarantees.
